Corvus Pharmaceuticals (CRVS) EBIT (2015 - 2026)
Corvus Pharmaceuticals' (CRVS) quarterly EBIT came in at -$14.9 million in Q1 2026, down 49.94% year-on-year from -$29.7 million in Q1 2025, and down 40.72% quarter-over-quarter from -$10.6 million in Q3 2025.
Corvus Pharmaceuticals (CRVS) EBIT (2015 - 2026) Analysis & Trends
Corvus Pharmaceuticals' EBIT history runs 12 years deep, the most recent figure standing at -$14.9 million for Q1 2026.
- On a quarterly basis, EBIT fell 49.94% year-over-year to -$14.9 million in Q1 2026; TTM through Mar 2026 was -$45.6 million, a 55.39% decrease from a year earlier, with the FY2023 full-year figure at -$23.4 million, up 28.12% from the prior year.
- EBIT retreated to -$14.9 million in Q1 2026 per CRVS's latest filing, from -$10.6 million in the prior quarter.
- Across five years, EBIT topped out at -$5.6 million in Q3 2023 and bottomed at -$14.9 million in Q1 2026.
- The 5-year median for EBIT is -$7.0 million (2022), against an average of -$8.1 million.
- Across the five-year window, EBIT surged 55.42% in 2023 and sank 72.87% in 2025, its largest moves.
- Year by year, EBIT stood at -$5.7 million in 2022, then grew by 0.26% to -$5.7 million in 2023, then slipped by 28.38% to -$7.3 million in 2024, then tumbled by 45.72% to -$10.6 million in 2025, then sank by 40.72% to -$14.9 million in 2026.
- Per Business Quant, the three latest CRVS EBIT figures stand at -$14.9 million (Q1 2026), -$10.6 million (Q3 2025), and -$10.3 million (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Corvus Pharmaceuticals | 1.23 Bn | 1.23 Bn | - | -14.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.88 Mn |
| Sep 30, 2025 | -10.57 Mn |
| Jun 30, 2025 | -10.26 Mn |
| Mar 31, 2025 | -9.92 Mn |
| Sep 30, 2024 | -7.26 Mn |
| Jun 30, 2024 | -5.94 Mn |
| Mar 31, 2024 | -6.25 Mn |
| Dec 31, 2023 | -5.65 Mn |
| Sep 30, 2023 | -5.56 Mn |
| Jun 30, 2023 | -5.62 Mn |
| Mar 31, 2023 | -6.57 Mn |
| Dec 31, 2022 | -5.67 Mn |
| Sep 30, 2022 | -12.47 Mn |
| Jun 30, 2022 | -7.01 Mn |
| Mar 31, 2022 | -7.41 Mn |
| Dec 31, 2021 | -6.81 Mn |
| Sep 30, 2021 | -9.05 Mn |
| Jun 30, 2021 | -11.29 Mn |
| Mar 31, 2021 | -11.48 Mn |
| Dec 31, 2020 | -9.88 Mn |